Basic Study
Copyright ©The Author(s) 2022.
World J Gastrointest Oncol. Oct 15, 2022; 14(10): 1981-2003
Published online Oct 15, 2022. doi: 10.4251/wjgo.v14.i10.1981
Table 1 Clinical characteristics of The Cancer Genome Atlas Live Hepatocellular Carcinoma sample training and test groups (n = 343)
Covariates
Sub type
Entire TCGA-LIHC, n (%)
Test group, n (%)
Training group, n (%)
P value
Age (yr)≤ 65216 (62.97)103 (60.23)113 (65.70)0.3493
> 65127 (37.03)68 (39.77)59 (34.30)
GenderFemale110 (32.07)59 (34.50)51 (29.65)0.3971
Male233 (67.93)112 (65.50)121 (70.35)
GradeG153 (15.45)27 (15.79)26 (15.12)0.3
G2161 (46.94)85 (49.71)76 (44.19)
G3112 (32.65)54 (31.58)58 (33.72)
G412 (3.50)3 (1.75)9 (5.23)
Unknown5 (1.46)2 (1.17)3 (1.74)
StageStage I161 (46.94)81 (47.37)80 (46.51)0.9079
Stage II77 (22.45)39 (22.81)38 (22.09)
Stage III80 (23.32)38 (22.22)42 (24.42)
Stage IV3 (0.87)2 (1.17)1 (0.58)
Unknown22 (6.41)11 (6.43)11 (6.40)
TT1168 (48.98)86 (50.29)82 (47.67)0.5683
T284 (24.49)42 (24.56)42 (24.42)
T375 (21.87)37 (21.64)38 (22.09)
T413 (3.79)4 (2.34)9 (5.23)
Unknown3 (0.87)2 (1.17)1 (0.58)
MM0245 (71.43)118 (69.01)127 (73.84)0.9551
M13 (0.87)2 (1.17)1 (0.58)
Unknown95 (27.70)51 (29.82)44 (25.58)
NN0239 (69.68)111 (64.91)128 (74.42)0.9081
N13 (0.87)2 (1.17)1 (0.58)
Unknown101 (29.45)58 (33.92)43 (25.00)